New York State Common Retirement Fund
ENTA icon

New York State Common Retirement Fund’s Enanta Pharmaceuticals ENTA Stock Holding History

New York State Common Retirement Fund’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.5K Hold
6,071
– – ﹤0.01% 2761
2026
Q1 		$76.7K Hold
6,071
– – ﹤0.01% 2644
2025
Q4 		$95.7K Sell
6,071
-1,700
-22% -$21.6K ﹤0.01% 2621
2025
Q3 		$93K Hold
7,771
– – ﹤0.01% 2650
2025
Q2 		$58.7K Hold
7,771
– – ﹤0.01% 2898
2025
Q1 		$42.9K Hold
7,771
– – ﹤0.01% 2829
2024
Q4 		$44.7K Hold
7,771
– – ﹤0.01% 2880
2024
Q3 		$80.5K Hold
7,771
– – ﹤0.01% 2696
2024
Q2 		$101K Buy
7,771
+41
+0.5% +$553 ﹤0.01% 2828
2024
Q1 		$135K Sell
7,730
-42
-0.5% -$556 ﹤0.01% 2623
2023
Q4 		$73.1K Sell
7,772
-2,340
-23% -$21.8K ﹤0.01% 2864
2023
Q3 		$113K Buy
10,112
+56
+0.6% +$902 ﹤0.01% 2656
2023
Q2 		$215K Buy
10,056
+156
+2% +$4.6K ﹤0.01% 2461
2023
Q1 		$400K Sell
9,900
-4,800
-33% -$229K ﹤0.01% 2288
2022
Q4 		$684K Hold
14,700
– – ﹤0.01% 2161
2022
Q3 		$762K Sell
14,700
-5
-0% -$292 ﹤0.01% 2107
2022
Q2 		$695K Sell
14,705
-4,836
-25% -$262K ﹤0.01% 2198
2022
Q1 		$1.39M Sell
19,541
-11,365
-37% -$740K ﹤0.01% 1935
2021
Q4 		$2.31M Sell
30,906
-448
-1% -$35.2K ﹤0.01% 1694
2021
Q3 		$1.78M Sell
31,354
-2,353
-7% -$116K ﹤0.01% 1818
2021
Q2 		$1.48M Sell
33,707
-4,191
-11% -$205K ﹤0.01% 2042
2021
Q1 		$1.87M Hold
37,898
– – ﹤0.01% 1818
2020
Q4 		$1.6M Buy
37,898
+6,550
+21% +$288K ﹤0.01% 1797
2020
Q3 		$1.44M Hold
31,348
– – ﹤0.01% 1733
2020
Q2 		$1.57M Buy
31,348
+8,550
+38% +$442K ﹤0.01% 1645
2020
Q1 		$1.17M Buy
22,798
+100
+0.4% +$5.33K ﹤0.01% 1651
2019
Q4 		$1.4M Sell
22,698
-3,700
-14% -$229K ﹤0.01% 1788
2019
Q3 		$1.59M Sell
26,398
-7,749
-23% -$576K ﹤0.01% 1753
2019
Q2 		$2.88M Sell
34,147
-300
-0.9% -$27K ﹤0.01% 1475
2019
Q1 		$3.29M Buy
34,447
+200
+0.6% +$17.9K ﹤0.01% 1399
2018
Q4 		$2.43M Sell
34,247
-3,590
-9% -$275K ﹤0.01% 1469
2018
Q3 		$3.23M Sell
37,837
-2,242
-6% -$225K ﹤0.01% 1450
2018
Q2 		$4.64M Buy
40,079
+6,306
+19% +$629K 0.01% 1295
2018
Q1 		$2.73M Sell
33,773
-5,465
-14% -$421K ﹤0.01% 1471
2017
Q4 		$2.3M Sell
39,238
-10,180
-21% -$510K ﹤0.01% 1562
2017
Q3 		$2.31M Buy
49,418
+12,340
+33% +$496K ﹤0.01% 1558
2017
Q2 		$1.33M Sell
37,078
-6,697
-15% -$214K ﹤0.01% 1894
2017
Q1 		$1.35M Buy
43,775
+901
+2% +$28.1K ﹤0.01% 1881
2016
Q4 		$1.44M Buy
42,874
+2,864
+7% +$82.1K ﹤0.01% 1868
2016
Q3 		$1.06M Sell
40,010
-105,014
-72% -$2.44M ﹤0.01% 1969
2016
Q2 		$3.2M Buy
145,024
+4,174
+3% +$109K ﹤0.01% 1417
2016
Q1 		$4.14M Buy
140,850
+7,281
+5% +$203K 0.01% 1288
2015
Q4 		$4.41M Buy
133,569
+9,871
+8% +$322K 0.01% 1283
2015
Q3 		$4.47M Buy
123,698
+4,084
+3% +$175K 0.01% 1266
2015
Q2 		$5.38M Buy
119,614
+14,600
+14% +$568K 0.01% 1312
2015
Q1 		$3.22M Buy
105,014
+46,768
+80% +$1.82M ﹤0.01% 1434
2014
Q4 		$2.96M Buy
58,246
+16,976
+41% +$760K ﹤0.01% 1445
2014
Q3 		$1.63M Sell
41,270
-15,930
-28% -$635K ﹤0.01% 1708
2014
Q2 		$2.46M Buy
+57,200
New +$2.18M ﹤0.01% 1582

Other funds holding ENTA

CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund's ENTA Position: Q2 2026 in Review

New York State Common Retirement Fund held its Enanta Pharmaceuticals (ENTA) position steady in Q2 2026 at 6,071 shares worth $88.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2761.

New York State Common Retirement Fund first reported a position in ENTA in Q2 2014 and has held it in 49 quarters since. The position peaked at $5.38M in Q2 2015. 22 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • New York State Common Retirement Fund held 6,071 shares of Enanta Pharmaceuticals worth $88.5K as of Q2 2026.
  • New York State Common Retirement Fund left its Enanta Pharmaceuticals share count unchanged in Q2 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2761 holding.
  • New York State Common Retirement Fund first reported a position in Enanta Pharmaceuticals in Q2 2014 and has held it in 49 quarters since.
  • New York State Common Retirement Fund's Enanta Pharmaceuticals position peaked at $5.38M in Q2 2015.
  • 22 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.